Retatrutide is a synthetic peptide investigated in published research as a triple agonist of the GLP-1, GIP, and glucagon receptors. It is supplied here as a research chemical for laboratory study of incretin and glucagon receptor pharmacology. It is not a licensed medicine and is not supplied for any therapeutic use.
For laboratory research use only. Not for human or veterinary consumption. Not evaluated or approved for the diagnosis, treatment, cure, or prevention of any disease.
COAs are not currently published on product pages. Where applicable, selected batches are independently tested through Janoshik Analytical, with testing documentation available for relevant products. Request available batch documentation by emailing redlinelabsltd@pm.me with the product name and SKU Ret1010.
This storefront lists Australia-wide dispatch. Orders are typically processed within 1–3 business days after payment confirmation. Delivery dates are not guaranteed. See the shipping policy.
